07.12.2016 20:00:00
|
Neogen names Kephart as chief science officer
LANSING, Mich., Dec. 7, 2016 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today it has named Dr. Dan Kephart as its chief science officer — a new position for the company. Kephart will assume his responsibilities at Neogen effective Jan. 1.
Kephart has served as research and development director for the agribusiness unit of Thermo Fisher Scientific, as well as animal health and food safety development at Life Technologies. His extensive industry experience also includes the management of a team focused on technical applications and customer-facing solutions for Promega Corporation.
"Neogen's substantial growth has necessitated the creation of the position of chief science officer to enhance the oversight and direction of our global scientific efforts," said James Herbert, Neogen's chief executive officer. "We are very pleased to announce the selection of Dr. Kephart for the position. Dan has a proven track record of innovating in applied testing applications for food and agriculture, including method development for the detection and analysis of pathogens and spoilage organisms, as well as applications related to genomic and metagenomics analysis. His experience and expertise in technology scouting, product design, and instrument integration will broaden Neogen's continued rapid growth in the development of solutions for both food and animal safety."
At Neogen, Kephart will work with the company's research and development teams, as well as innovative global manufacturing operations. Neogen has a number of research and manufacturing operations in the United States, as well as in the United Kingdom, Brazil, Mexico, India and China. Kephart and his wife, Cindy, will be relocating to Lansing, Mich., from Austin, Texas, in late December.
Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.
CONTACT: Steven J. Quinlan, |
Neogen Vice President & CFO |
517/372-9200 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neogen-names-kephart-as-chief-science-officer-300374695.html
SOURCE Neogen Corporation
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Neogen Corp.mehr Nachrichten
12.12.24 |
NASDAQ Composite Index-Wert Neogen-Aktie: So viel hätten Anleger an einem Neogen-Investment von vor einem Jahr verloren (finanzen.at) | |
11.12.24 |
Börse New York in Grün: NASDAQ Composite klettert am Nachmittag (finanzen.at) | |
11.12.24 |
Freundlicher Handel: NASDAQ Composite legt am Mittag zu (finanzen.at) | |
05.12.24 |
NASDAQ Composite Index-Wert Neogen-Aktie: So viel Verlust hätte eine Investition in Neogen von vor 10 Jahren bedeutet (finanzen.at) | |
03.12.24 |
NASDAQ Composite-Handel aktuell: NASDAQ Composite am Mittag im Aufwind (finanzen.at) | |
28.11.24 |
NASDAQ Composite Index-Wert Neogen-Aktie: So viel hätten Anleger an einem Neogen-Investment von vor 5 Jahren verloren (finanzen.at) | |
26.11.24 |
NASDAQ-Handel: NASDAQ Composite notiert am Nachmittag im Plus (finanzen.at) | |
26.11.24 |
Börse New York in Grün: So bewegt sich der NASDAQ Composite am Mittag (finanzen.at) |